Latest stories on BOLT
Bolt Biotherapeutics GAAP EPS of -$4.57 beats by $16.49, revenue of $0.005M
Seeking Alpha56 · neutralearnings
Bolt Biotherapeutics reports Q2 EPS ($4.57) vs. ($4.46) last year
The Fly48 · neutralearnings
Bolt Biotherapeutics, Inc. (BOLT) files 8-K
SEC 8-K50 · neutralgeneral
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider56 · neutralearnings
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan50 · neutralearnings
Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting
TipRanks50 · neutralgeneral
Bolt Biotherapeutics, Inc. (BOLT) files 8-K
SEC 8-K50 · neutralgeneral